Patients are encouraged to report any suspected adverse reactions to medicines via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app)
D., Pal, S., Yang, L., Sawhney, B., Boggs, R., Rajpathak, S., & Iglay, K
If you have questions about whether GLP-1 medications are still the right option for you, I encourage you to schedule a consultation today
Use the peptide reconstitution calculator to determine your exact mixing ratios, and note the date you reconstitute on the vial
SURMOUNT-5 trial: 5.9% mean weight loss Glapp users: 7.5% mean weight loss Relative improvement: +27.1% Key insight: Over the first 12 weeks, digitally engaged semaglutide users achieved approximately 2530% greater weight reduction compared to clinical trial participants receiving identical pharmacotherapy
Elisabetta Bugianesi 15